Joint home program for older adults with poorly controlled type 2 diabetes and caregivers
Tests a home telephone program for patients and caregivers together, with type 2 diabetes.
Key facts
- Who runs it
- Medical College of Wisconsin
- Where
- Milwaukee, United StatesSee the site
- Trial code
- Registry title
- Joint Patient and Caregiver Intervention for Older African Americans With Type 2 Diabetes
- Status
- Recruiting
- People taking part
- 100 people, planned
- Started
- 4 Mar 2024
- Planned end
- 31 Jul 2026
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Joint Home-DM-BAT Intervention
- Usual Care
- Record updated
- 29 July 2025
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for older African American adults with poorly controlled type 2 diabetes who have a family member or close friend willing to take part with them.
- Age
- 50 years and older (up to 120 years).
- Sex
- All sexes can join.
- Disease stage
- Clinical diagnosis of type 2 diabetes that is poorly controlled, with HbA1c of 8% (64 mmol/mol) or higher at the screening visit.
- Biomarker or test result
- HbA1c of 8% (64 mmol/mol) or higher at the screening visit.
Main reasons for not taking part
- Mental confusion at screening suggesting significant dementia
- Alcohol or drug abuse or dependency at screening
- Active psychosis or acute mental disorder at screening
- Life expectancy under 6 months at screening
- Cannot communicate in English
The registry criteria, word for word
Show all 13 criteriaShow less
Other criteria
- Patient Inclusion Criteria:
- Age ≥50 years of age
- Self-identified as Black/African American
- Clinical diagnosis of T2DM and poorly controlled, defined as HbA1c ≥8% at the screening visit
- Able to communicate in English; and
- Has an informal caregiver (family member or close friend willing to participate in the study for 6 months; Caregiver Inclusion Criteria:
- Willing to attend 4, one-hour sessions with the study participant
- Willing to support the study participant for study duration (6 months); and
- Willing to complete brief baseline, 3- and 6-month assessments; Patient/Caregiver Exclusion Criteria:
- Mental confusion at screening assessment suggesting significant dementia
- Alcohol or drug abuse/dependency at screening assessment
- Active psychosis or acute mental disorder at screening assessment; and
- Life expectancy <6 months at screening
Check if you might fit
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 50 and 120 years old?
Where in United States
- Medical College of WisconsinMilwaukee, United StatesContact: Aprill DawsonTaking people
About the trial
What the trial wants to find out
This study will test the preliminary efficacy of a joint patient/informal caregiver telephone-delivered intervention that includes diabetes education; problem solving around social needs; and behavioral activation for older African Americans with poorly controlled type 2 diabetes by randomizing 100 patient/caregiver dyads to the Joint Home intervention (n=50) and usual care (n=50) arms.
Read full original descriptionShow less
The aims of the study are:
Aim 1: To test the preliminary efficacy of home-based, joint patient and caregiver intervention (Joint Home-DM-BAT) on patient clinical outcomes (hemoglobin A1c, blood pressure, and LDL-Cholesterol).
Aim 2: To test the preliminary efficacy of home-based, joint patient and caregiver intervention (Joint Home-DM-BAT) Joint Home DM-BAT on patient quality of life.
Aim 3: To test the preliminary efficacy of home-based, joint patient and caregiver intervention (Joint Home-DM-BAT) on caregiver quality of life and caregiver burden.
The 2 groups in the trial
- Joint Home-DM-BAT InterventionTreatment being tested
A trained health educator will deliver the manualized Joint Home-DM-BAT intervention. Participants will receive 8-weekly sessions of diabetes education, problem solving around social needs, and behavioral activation via telephone; and 3 monthly booster sessions.
- Usual CareExisting treatment, for comparison
Patients randomized to the usual care arm will receive weekly mailings of diabetes education modules for 8 weeks and monthly mailings for 3 months to match the weekly and monthly booster sessions.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Joint Patient and Caregiver Intervention for Older African Americans With Poorly Controlled Type 2 Diabetes (Joint Home-DM-BAT)
- Plain-language title
- Joint home program for older adults with poorly controlled type 2 diabetes and caregiversGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Fit questions
- Built from NCT06279637, who can take part
- Record updated
- 29 July 2025